(Q36616318)

15 August 2017

Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years (English)

1 reference

15 August 2017

S Moss

1

1 reference

15 August 2017

I Thomas

2

1 reference

15 August 2017

A Evans

3

1 reference

15 August 2017

B Thomas

4

1 reference

15 August 2017

L Johns

5

1 reference

15 August 2017

Trial Management Group

6

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

92

1 reference

15 August 2017

5

1 reference

15 August 2017

949-954

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602396

15 August 2017

0 references

cites work

Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361899

Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361899

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361899

Estimating the sensitivity of a screening test

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361899

Calculation of sample size in trials of screening for early diagnosis of disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361899

The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361899

A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361899

Radiation doses in the UK trial of breast screening in women aged 40-48 years

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15726102

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15726102

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15726102

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6602396

1 reference

15 August 2017

1 reference

15 August 2017

1 reference